Knowledge Center
Webinar / Nov 19, 2018
Webinar - Amorphous Solid Dispersions: Increasing Solubility From API to Tablet
Source:
Webinar

Speakers |
---|
João Henriques - Team Leader |
Paulo Lino - Scientist |
Up to 90% of the drugs in the pharmaceutical pipeline are classified as poorly soluble, according to the Biopharmaceutical Classification System. Amorphous solid dispersions have emerged as one of the preferred methods to increase aqueous solubility of drugs.
This webinar will focus on several aspects of the formulation screening of amorphous solid dispersions, for both the drug product intermediate and the final drug product.
Key Learning Objectives:
- Overview of amorphous solid dispersion as an enabling technique in the pharmaceutical industry
- Screening methodologies for amorphous solid dispersions
- Drug product formulation of amorphous solid dispersions
Watch On-Demand Webinar!
(Restricted Access)
Also in the Knowledge Center
/ Apr 01, 2024
Striving for Uniformity: A Review on Advances and Challenges To Achieve Uniform Polyethylene Glycol
Read more
Scientific Article
/ May 06, 2024
Ten years of the manufacturing classification system: a review of literature applications and an extension of the framework to continuous manufacture
Read more
Scientific Article
/ Dec 28, 2023
Pharmaceutical composition containing sugar and lipid composite particles for inhalation and method for manufacturing same
Read more
Scientific Article